Valuation: Sagittarius Life Science Corp

Market Cap 317.46Cr 9.97Cr 8.7Cr 8.21Cr 7.46Cr 14Cr 957.09Cr 14Cr 98Cr 38Cr 486.6Cr 37Cr 37Cr 1.57TCr P/E 2024
-21.4x
P/E 2025 -55.9x
Enterprise Value 237.15Cr 7.45Cr 6.5Cr 6.13Cr 5.57Cr 10Cr 714.95Cr 10Cr 73Cr 28Cr 363.49Cr 28Cr 27Cr 1.17TCr EV / Sales 2024
1.9x
EV / Sales 2025 7.69x
Free-Float
29.82%
Yield 2024 *
-
Yield 2025 -
14/08 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
14/05 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
16/03 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2025 CI
13/11 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
12/25/12 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
14/25/14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
13/25/13 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/24/14 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
13/24/13 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
15/24/15 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/24/21 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI
14/23/14 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
14/23/14 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
1 day+0.75%
1 week+0.86%
1 month-3.39%
3 months-10.65%
6 months-7.30%
Current year-8.38%
1 week 46
Extreme 46
47.85
1 month 45.8
Extreme 45.8
49.8
Current year 45.8
Extreme 45.8
67
1 year 43.95
Extreme 43.95
67
3 years 21.3
Extreme 21.3
67
5 years 20.65
Extreme 20.65
79.2
10 years 20.65
Extreme 20.65
167
Manager TitleAgeSince
Chief Executive Officer - 30/09/2019
Director of Finance/CFO - 15/11/2019
Director TitleAgeSince
Chairman - 29/04/2004
Director/Board Member - 17/06/2015
Director/Board Member - 29/04/2004
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%+0.86%-6.93%+9.56% 9.88Cr
-0.34%-0.72%+9.67%+61.37% 1.21TCr
+1.41%+3.49%-15.29%+214.36% 898.48Cr
-0.11%-0.65%-23.53%-51.98% 230.79Cr
-0.92%+1.19%-15.90%-11.66% 146.47Cr
0.00%-0.18%+20.06%+73.96% 134.69Cr
+1.71%-1.08%+28.12%-17.83% 122.52Cr
+2.02%+8.72%-41.25% - 106.41Cr
-1.43%-1.75%-75.52%-77.73% 105.93Cr
+0.80%+2.95%-62.31%-71.12% 89Cr
Average +0.39%+0.24%-18.29%+14.33% 305.25Cr
Weighted average by Cap. +0.34%-0.62%-7.10%+83.63%

Financials

2024 2025
Net sales 47Cr 1.47Cr 1.28Cr 1.21Cr 1.1Cr 2.06Cr 141.02Cr 2.07Cr 14Cr 5.59Cr 72Cr 5.52Cr 5.4Cr 230.69Cr 35Cr 1.09Cr 94.82L 89.53L 81.3L 1.52Cr 104.34Cr 1.53Cr 11Cr 4.14Cr 53Cr 4.08Cr 3.99Cr 170.68Cr
Net income -4.85Cr -15.25L -13.3L -12.55L -11.4L -21.36L -15Cr -21.45L -1.5Cr -58.03L -7.44Cr -57.28L -56.01L -24Cr -4.96Cr -15.57L -13.58L -12.82L -11.64L -21.81L -15Cr -21.91L -1.54Cr -59.27L -7.6Cr -58.5L -57.2L -24Cr
Net Debt -15Cr -47.17L -41.13L -38.84L -35.27L -66.08L -45Cr -66.36L -4.65Cr -1.8Cr -23Cr -1.77Cr -1.73Cr -74Cr -80Cr -2.52Cr -2.2Cr -2.08Cr -1.89Cr -3.53Cr -242.14Cr -3.55Cr -25Cr -9.6Cr -123.11Cr -9.48Cr -9.27Cr -396.11Cr
Logo Sagittarius Life Science Corp
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Employees
112
Date Price Change Volume
18/26/18 NT$47.00 +0.75% 3,339
17/26/17 NT$46.65 +0.76% 19,550
16/26/16 NT$46.30 -0.11% 24,628
15/26/15 NT$46.35 -0.11% 5,314
14/26/14 NT$46.40 -0.43% 9,104
  1. Stock Market
  2. Stocks
  3. 3205 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!